Integral Health Asset Management »

Repligen Corporation shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Repligen Corporation (RGEN) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Repligen Corporation

Tip: Access up to 7 years of quarterly data

All positions including Repligen Corporation held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Repligen Corporation by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.5M 20k 127.24
2024-12-31 $5.8M 40k 143.94
2024-06-30 $7.6M 60k 126.06
2024-03-31 $9.2M 50k 183.92

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Repligen Corporation

BlackRock
Vanguard Group
United Capital Financial Advisers
FMR
State Street Corporation
Citadel Advisors
Point72 Asset Management
Holocene Advisors
Champlain Investment Partners
Bank of New York Mellon
Alliancebernstein
Geode Capital Management
Conestoga Capital Advisors
Millennium Management
Invesco

View all funds holding Repligen Corporation